BioAtla (BCAB) Return on Capital Employed (2021 - 2025)

BioAtla (BCAB) has disclosed Return on Capital Employed for 5 consecutive years, with 8.41% as the latest value for Q4 2025.

  • For Q4 2025, Return on Capital Employed rose 1014.0% year-over-year to 8.41%; the TTM value through Dec 2025 reached 8.41%, up 1014.0%, while the annual FY2025 figure was 5.29%, 426.0% down from the prior year.
  • Return on Capital Employed hit 8.41% in Q4 2025 for BioAtla, up from 18.76% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 8.41% in Q4 2025 and bottomed at 18.76% in Q3 2025.
  • Average Return on Capital Employed over 5 years is 1.53%, with a median of 0.68% recorded in 2023.
  • On a YoY basis, Return on Capital Employed climbed as much as 1014bps in 2025 and fell as far as -1688bps in 2025.
  • BioAtla's Return on Capital Employed stood at 0.39% in 2021, then crashed by -50bps to 0.59% in 2022, then tumbled by -106bps to 1.21% in 2023, then crashed by -43bps to 1.73% in 2024, then soared by 587bps to 8.41% in 2025.
  • According to Business Quant data, Return on Capital Employed over the past three periods came in at 8.41%, 18.76%, and 3.96% for Q4 2025, Q3 2025, and Q2 2025 respectively.